Uniswap Founder Hayden Adams blasts the Wall Street giant Citadel Securities, accusing it of attempting to impose the regulatory standards of the traditional financial world on decentralized finance, or DeFi. This follows calls by the latter for the U.S. Securities and Exchange Commission (SEC) to classify DeFi, as well as the people behind it, as […]Uniswap Founder Hayden Adams blasts the Wall Street giant Citadel Securities, accusing it of attempting to impose the regulatory standards of the traditional financial world on decentralized finance, or DeFi. This follows calls by the latter for the U.S. Securities and Exchange Commission (SEC) to classify DeFi, as well as the people behind it, as […]

Uniswap Founder Slams Citadel for Pushing Wall Street Rules on DeFi

2025/12/04 22:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
  • Uniswap founder Hayden Adams criticizes Citadel for trying to impose traditional finance rules on DeFi.
  • Adams highlights Citadel’s past interference in ConstitutionDAO and ongoing lobbying with the SEC.
  • Citadel argues that most DeFi platforms resemble exchanges, pushing for strict regulatory oversight on developers.

Uniswap Founder Hayden Adams blasts the Wall Street giant Citadel Securities, accusing it of attempting to impose the regulatory standards of the traditional financial world on decentralized finance, or DeFi. This follows calls by the latter for the U.S. Securities and Exchange Commission (SEC) to classify DeFi, as well as the people behind it, as the rest of the financial industry.

Adams shared his views on X, which soon got popular support from the crypto world. “First, Ken Griffin stabbed ConstitutionDAO in the back. This was after the involvement of his firm, Citadel, during the snobbish auction of the rare US Constitution booklet back in 2021. This time, it’s coming for DeFi, and it’s asking the SEC to treat software engineers for decentralized systems as it would middlemen.”

He specifically linked to the SEC filing for the Citadel, saying, “Bet Citadel has been lobbying for years for this one privately.”

image.pngSource: SEC

Uniswap Founder Blasts Citadel Over DeFi

The Uniswap founder was not one to beat around the bush while blasting the arguments that the Citadel had raised regarding DeFi. The Uniswap founder expressed the following quote:
“Okay, that’s all pretty bad, but the actual nerve for one of their arguments to be that there is no way for DeFi protocols to provide ‘fair access’ to all things, lmao.”

He continued, “Makes sense the king of shady tradfi market makers doesn’t like open source, peer-to-peer tech that lowers barriers to liquidity creation.”

Uniswap Criticizes Citadel DeFi Regulation

This dispute arose as a result of an explanatory letter that the Citadel Securities company had written to the SEC, pointing out that most DeFi platforms qualify as traditional exchanges and broker-dealers because they link buyers and sellers in an organized manner. This means that such platforms are not exempt from regulations merely because they are based on blockchain code.

In this case, the Citadel defendants identified various players in the DeFi space, such as interfaces, developers, validators, and liquidity providers, and alleged that most of them are like the intermediaries that are regulatory compliant.

Citadel had worries that the tokenized version of U.S. stocks traded on DeFi markets could spark the development of a “shadow market” and undermine the protections afforded to investors. They were also against the exemption of open-source protocols as they could be considered intermediaries.

Also Read | South Korean Crypto Exchange Loses $35 Million in 15-Minute Hot Wallet Hack

SEC Targets DeFi Protocol Developers

If the SEC were to adopt the recommendations put forth by Citadel, protocol development teams, frontline operators, routing wallets, and even DAO participants could find themselves required to strictly register and comply with regulations applicable to broker-dealers. This, many people believe, would be impossible for software that is both decentralized and permissionless.

Adams put the situation into context as the continuation of the struggle between Wall Street and the world of DeFi. Through the hinting of the past incident involving ConstitutionDAO, Adams portrayed the firm as one that has always been an obstacle to crypto-driven initiatives and has brought that attitude to Washington.

Also Read | Bybit, Mantle, and Aave Unite to Expand Global DeFi Liquidity Access

Market Opportunity
DeFi Logo
DeFi Price(DEFI)
$0.000356
$0.000356$0.000356
+11.94%
USD
DeFi (DEFI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09